Abstract
1 Bronchodilator efficacy of four beta 2-sympathomimetic aerosols, fenoterol, orciprenaline, salbutamol and terbutaline has been compared in nine patients with chronic stable reversible airways obstruction using a double-blind placebo controlled cross-over design. Two puffs of each agent were given on two separate occasions to each of the patients and the forced expiratory volume in one second (FEV1) and the vital capacity (VC) were measured before and 30, 90, 150 and 210 min after administration. 2 Multivariate analysis of the data at 30 min showed FEV1 and VC in these patients to be so highly correlated that they could be considered as a single variable. 3 When absolute change in VC at 30 min was used as the response criterion, efficacy of the four drugs was significantly better than placebo (P < 0.01). It was not possible to rank all four drugs in order of effectiveness; fenoterol and salbutamol were significantly better than terbutaline and orciprenaline (P < 0.01) but this was complicated by a significant interaction effect between drugs and patients (P < 0.01). 4 Similar results were obtained when absolute and relative changes in FEV1 and VC and area under the curve were used as response variables. 5 The study demonstrates that important individual differences in patient response may be concealed if only average drug effects are considered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blackhall M. I., Dauth M., Mahoney M., O'Donnell S. R. Inhalation of fenoterol (Berotec) by asthmatic children: A clinical comparison with salbutamol, orciprenaline and isoprenaline. Med J Aust. 1976 Sep 18;2(12):439–444. doi: 10.5694/j.1326-5377.1976.tb130323.x. [DOI] [PubMed] [Google Scholar]
- Freedman B. J. Trial of a terbutaline aerosol in the treatment of asthma and a comparison of its effects with those of a salbutamol aerosol. Br J Dis Chest. 1972 Jul;66(3):222–229. [PubMed] [Google Scholar]
- Gaddie J., Legge J. S., Palmer K. N. Aerosols of salbutamol, terbutaline and isoprenaline-phenylephrine in asthma. Br J Dis Chest. 1973 Jul;67(3):215–220. doi: 10.1016/0007-0971(73)90056-9. [DOI] [PubMed] [Google Scholar]
- Leifer K. N., Wittig H. J. Annals of allergy. Ann Allergy. 1975 Aug;35(2):69–80. [PubMed] [Google Scholar]
- Minette A. Spirometric study of the bronchodilating effects of hydroxyphenylorciprenaline (Th 1165 a) in various forms in a group of 124 coal miners suffering from bronchospasm. Respiration. 1970;27(3):276–315. doi: 10.1159/000192688. [DOI] [PubMed] [Google Scholar]
- Paterson J. W., Shenfield G. M. Bronchodilators. Part II. BTTA Rev. 1974 Dec;4(4):61–74. [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Racoveanu C., Stanescu D. C., Manicatide M., Stroescu V. The bronchodilator effects of orciprenaline and salbutamol. A double-blind study. Postgrad Med J. 1971 Mar;47(Suppl):83–86. [PubMed] [Google Scholar]
- Shenfield G. M., Paterson J. W. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 1973 Mar;28(2):124–128. doi: 10.1136/thx.28.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]